Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)
- Conditions
- terine cervical carcinoma
- Registration Number
- JPRN-UMIN000002937
- Lead Sponsor
- Japanese Cancer Clinical Research Organization(JACCRO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 70
Not provided
1) Patient with stump cancer 2) Patient who has an active infection. 3) Patient who has a hydronephrosis. 4) Patient who has myocardial infarction, unstable angina and uncontrolled irregular heartbeat within six months before registration. 5) Patient who has a serious complication. 6) Patient who has a radiotherapy history in the pelvic region. 7) Patient who has an active double cancer. However, cancers in situ that are considered as recovered by local treatment or legions equivalent to intramucosal cancer are not included in the active double cancers. 8) Patient who underwent exploratory laparotomy for cervical cancer. 9) Patient who is complicated by mental disease or psychological symptom and considered difficult to participate in the test. 10) Patient who is pregnant or of child-bearing potential or breast-feeding. 11) Patient who is diagnosed as a pyometra and there is no improvement in pyometra and infection despite the implementation of appropriate measures. 12) Other cases where doctors in attendance consider patients inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method